- Home
- Publications
- Publication Search
- Publication Details
Title
Management of adrenal cancer: a 2013 update
Authors
Keywords
Adjuvant treatment, Adrenal cancer, Adrenocortical carcinoma, Chemotherapy, Cisplatin, Mitotane, Overall survival, Recurrence-free survival
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 37, Issue 3, Pages 207-217
Publisher
Springer Nature
Online
2014-01-23
DOI
10.1007/s40618-013-0049-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study
- (2013) T Urup et al. BRITISH JOURNAL OF CANCER
- Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma
- (2013) A Naing et al. BRITISH JOURNAL OF CANCER
- Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993
- (2013) Thomas M.A. Kerkhofs et al. EUROPEAN JOURNAL OF CANCER
- Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection
- (2013) M Terzolo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane
- (2013) Antonio D’Avolio et al. Pharmacogenetics and Genomics
- Recent advances in adrenocortical carcinoma in adults
- (2013) Isabelle Bourdeau et al. Current Opinion in Endocrinology Diabetes and Obesity
- Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) A. Berruti et al. ANNALS OF ONCOLOGY
- Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates
- (2012) Eleonora Duregon et al. HUMAN PATHOLOGY
- Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
- (2012) Matthias Kroiss et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement
- (2012) Vasileios Chortis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy after Primary Surgical Resection in Patients with Adrenocortical Carcinoma
- (2012) Mouhammed Amir Habra et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combination Chemotherapy in Advanced Adrenocortical Carcinoma
- (2012) Martin Fassnacht et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy
- (2012) Barbra S. Miller et al. SURGERY
- Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer
- (2011) Aung Naing et al. CLINICAL CANCER RESEARCH
- Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
- (2011) Matthias Kroiss et al. CLINICAL ENDOCRINOLOGY
- High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up
- (2011) Sophie Mauclère-Denost et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma
- (2011) Alfredo Berruti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study
- (2011) Ilse G. Hermsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adrenocortical carcinoma: effect of hospital volume on patient outcome
- (2011) Celestino Pio Lombardi et al. LANGENBECKS ARCHIVES OF SURGERY
- Adrenocortical carcinoma: a clinician's update
- (2011) Martin Fassnacht et al. Nature Reviews Endocrinology
- The Weiss Score and Beyond—Histopathology for Adrenocortical Carcinoma
- (2011) Mauro Papotti et al. Hormones & Cancer
- Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study
- (2010) Paola Sperone et al. ENDOCRINE-RELATED CANCER
- Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma
- (2010) Pasqualino Malandrino et al. ENDOCRINE-RELATED CANCER
- Therapeutic Concentrations of Mitotane (o,p′-DDD) Inhibit Thyrotroph Cell Viability and TSH Expression and Secretion in a Mouse Cell Line Model
- (2010) Maria Chiara Zatelli et al. ENDOCRINOLOGY
- Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?
- (2010) S Leboulleux et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients
- (2010) David Brix et al. EUROPEAN UROLOGY
- Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer
- (2010) Francesco Porpiglia et al. EUROPEAN UROLOGY
- Adjuvant and Definitive Radiotherapy for Adrenocortical Carcinoma
- (2010) Aaron Sabolch et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel
- (2010) Alfredo Berruti et al. JOURNAL OF CLINICAL ONCOLOGY
- Transcatheter Arterial Chemoembolization for Liver Metastases in Patients with Adrenocortical Carcinoma
- (2010) Julien Cazejust et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
- (2009) Paul Haluska et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma
- (2009) Wiebke Fenske et al. ENDOCRINE-RELATED CANCER
- Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
- (2009) Sebastian Wortmann et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification
- (2009) Marco Volante et al. HISTOPATHOLOGY
- Management of Endocrine Manifestations and the Use of Mitotane As a Chemotherapeutic Agent for Adrenocortical Carcinoma
- (2009) Irina Veytsman et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival
- (2009) Aurélien de Reyniès et al. JOURNAL OF CLINICAL ONCOLOGY
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma
- (2008) Martin Fassnacht et al. CANCER
- Adrenocortical carcinoma in the United States
- (2008) Karl Y. Bilimoria et al. CANCER
- Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
- (2008) F. Daffara et al. ENDOCRINE-RELATED CANCER
- Adjuvant Mitotane for Adrenocortical Cancer—A Recurring Controversy
- (2008) Hui Huang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Advanced Adrenocortical Carcinoma with Erlotinib plus Gemcitabine
- (2008) Marcus Quinkler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started